Pulse
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
Primo Chemicals Limited

Primo Chemicals Limited

NSE: PRIMO
ChemicalsBasic MaterialsSMALL CAPMCap ₹637.4 Cr
₹26.30₹1.72 (+7.00%)

Market Closed • NSE

Market cap₹637.4 Cr
Enterprise value₹733.0 Cr
P/E TTM40.46
P/B1.57
EPS TTM₹0.65
ROCE6.60%
D/E0.32
Dividend yield0.00%
Face value₹2.00
52W high₹29.80
52W low₹16.10
Price chart(1Y)
1Y Return:+19.71% (+₹4.33)
H: ₹29.8L: ₹19.26
1W+0.84%
1M+23.65%
3M+10.50%
6M+15.05%
1Y+10.88%
Today at a glance

Day range

₹24.51₹26.80

52 week range

₹16.10₹29.80
Volume310.9K0.52x 20D avg
Free float50.00%-48.00% volume

Primo Chemicals Limited closed at INR26.30 (+7%) on volume 0.52x its 20-day average, trading 11.74% below its 52-week high.

Technical analysis
RSI (14)58.3Neutral (30–70)
MACDBULLISHBullish (Above signal)
ATR (14)₹1.81High
SMA 20₹24.21BULLISH
SMA 50₹23.24BULLISH
SMA 100₹23.39BULLISH
SMA 200₹22.52BULLISH
CPR bottom₹25.02
Pivot₹24.87
CPR top₹24.73
What changed recently?

2026-Q2

Q2 FY2026 Financial Results

PAT moved -28.5% QoQ

Shariah audit
Methodology: AAOIFI Shariah Standard No. 21
PASS4/4 criteria
Shariah Compliant
CriteriaNumeratorDenominatorValueThresholdStatus
Interest-bearing debt ratio₹131.2 Cr₹637.4 Cr20.58%≤ 33%PASS
Non-halal income ratio–₹561.7 Cr0.00%≤ 5%PASS
Illiquid assets ratio₹691.5 Cr₹692.5 Cr99.85%≥ 20%PASS
Receivables ratio–₹692.5 Cr—≤ 49%PASS
Valuation & sector context
MetricCompanySector
P/E40.4621.40
Forward P/E——
P/B1.572.20
EV/EBITDA—18.00
PEG—1.00
Earnings yield2.504.70
Growth & profitability
RevenuePAT
FY24PAT margin -6.40%
FY25PAT margin 0.60%
FY26PAT margin 2.00%

Revenue and PAT bars use independent scales to make their year-on-year direction readable.

Revenue CAGR 3Y+0.80%
Revenue CAGR 5Y+7.20%
PAT CAGR 3Y+97.30%
PAT CAGR 5Y—
Operating margin8.95%
Net margin2.85%
Financial health & cash flow
Net debt₹130.1 CrModerate
Interest coverage0.80xEBIT / interest
CFO / PAT6.49x3Y average
Net debt / EBITDA—Leverage
Operating cash flow₹64.7 Cr
Capital expenditure–
Free cash flow₹38.7 Cr
Financial statements

Complete reported financial history · Values use the company's reporting currency

Hover over the chart for exact reported values. Percentage lines use the right-hand axis.

Fundamental scorecard
Overall53/100
Valuation50/100
Profitability50/100
Financial health60/100

A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.

Strengths, risks & investment thesis

Strengths

Low Debt Profile: Debt-to-Equity is comfortable at 0.32x

High Cash Flow Conversion: CFO/PAT averaged 6.49x over last 3 years

Risks

Tight Debt Servicing: Interest coverage ratio is under 2.0x

Bull case

Market Leadership: Established operational scale in Chemicals.

Bear case

Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.

Flip condition

Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.

Shareholding pattern
Quarterly ownership historyLatest valid period · December 2025

Ownership distribution

Dec 2025Latest holding

Category trends

Hover over a period for exact holdings

70%47%23%0%Sept 2024Dec 2024Jun 2025Sept 2025Dec 2025
2.01%Institutional holding
65.61%Public holding
5Periods available
0.00%Promoter pledged
48KShareholders
Delivery participation

Traded volume and delivery percentage across the latest 20 sessions

Average delivery (20D)58.87%-16.08% latest vs average
Highest delivery88.67%on 24 Sept
Average volume (20D)598.5KTrading-session average
Conviction trendWeakening-16.08% latest reading
Traded volumeDelivery %
Peer comparison

Compare valuation, latest quarterly performance and year-on-year growth

8 companies
Company nameMarket cap ₹ CrP/E ratioDividend yield %Quarterly sales ₹ CrProfit after tax ₹ CrSales growth %Profit growth %
UltraTech Cement Limited
UltraTech Cement LimitedULTRACEMCO
Open analysis
₹3.14L36.802.30%₹25,799.47₹2,982.76+11.86%+20.17%
JSW Steel Limited
JSW Steel LimitedJSWSTEEL
Open analysis
₹2.85L11.520.60%₹47,364.00₹4,651.00+11.55%+112.96%
Hindustan Zinc Limited
Hindustan Zinc LimitedHINDZINC
Open analysis
₹2.30L13.462.07%₹13,687.00₹5,425.00+77.22%+146.14%
Asian Paints Limited
Asian Paints LimitedASIANPAINT
Open analysis
₹2.24L47.081.19%₹10,541.94₹1,539.25+17.94%+39.96%
Tata Steel Limited
Tata Steel LimitedTATASTEEL
Open analysis
₹2.17L19.642.33%₹60,794.00₹2,385.00+14.32%+18.83%
Hindalco Industries Limited
Hindalco Industries LimitedHINDALCO
Open analysis
₹2.00L12.210.56%₹84,825.00₹7,013.00+32.06%+75.15%
Grasim Industries Limited
Grasim Industries LimitedGRASIM
Open analysis
₹1.96L34.470.35%₹11,794.71₹246.65-70.60%-82.61%
Solar Industries India Limited
Solar Industries India LimitedSOLARINDS
Open analysis
₹1.81L90.880.06%₹3,668.00₹666.00+70.29%+88.67%
About Primo Chemicals Limited
Primo Chemicals Limited

Incorporated in 1975, Primo Chemicals Ltd (formerly Punjab Alkalies & Chemicals Ltd) is in the business of manufacturing & selling of chemicals[1]

IndiaBasic Materials

Questions investors ask
Is Primo Chemicals Limited Shariah compliant?

Primo Chemicals Limited is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (20.58%) complies with AAOIFI threshold (≤ 33%).

What is Primo Chemicals Limited's current valuation relative to peers?

Primo Chemicals Limited trades at a P/E of 40.5x compared to the sector median of 21.4x, and a Price-to-Book of 1.6x.

Is the company financially healthy?

The company has a Debt-to-Equity ratio of 0.32x. Interest coverage is 0.8x.

What are the historical revenue and profit growth rates?

Over the past 5 years, revenue compounded at 7.2% while net profit growth averaged consistent levels.

Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.

Market data may be delayed. Quote date: 2026-10-09. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.